BAMBUSA THERAPEUTICS
Live / Applied — First extension granted (statement of use) (as of 03 Feb 2026)
What this means for you
Not registered yet, but its 16 Sept 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98752279
- Mark type
- Stylized text
- Filed
- 16 Sept 2024
- Published for opposition
- 17 Jun 2025
- Attorney of record
- Ilene B. Tannen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of inflammatory and immunological diseases and disorders for human use
Owner
- Bambusa Therapeutics, Inc., Boston, MA, US
- Bambusa Therapeutics, Inc., Boston, MA, US
Prosecution history
- 04 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Feb 2026 — SOU EXTENSION 1 GRANTED
- 03 Feb 2026 — SOU EXTENSION 1 FILED
- 03 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 12 Aug 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 17 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Jun 2025 — PUBLISHED FOR OPPOSITION
- 11 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 May 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED